logo

Cerus Corp (CERS)



Trade CERS now with
  Date
  Headline
9/6/2018 4:21:53 PM Cerus Appoints Timothy Moore To Board Of Directors
4/25/2018 8:37:29 AM Cerus: Health Canada Approves Commercialization Of INTERCEPT Blood System For Platelets
4/2/2018 8:33:07 AM Cerus’ RedeS Phase 3 Red Blood Cell Study Expands Into Continental U.S.
3/13/2018 7:36:54 AM Cerus Announces Fourth BLA Approval For U.S. Blood Center Customer
1/31/2018 9:05:16 AM Cerus Corp. Announces Pricing Of Public Offering Of Common Stock
1/8/2018 8:38:53 AM Cerus Q4 Product Revenue Of $16.2 Mln, Increase Of 60%
11/7/2017 8:34:50 AM Cerus Corp. Receives IDE Approval To Initiate Phase III ReCePI Study
10/30/2017 8:37:57 AM Cerus Reports Agreement With Transfusion Center Of The Community Of Madrid
10/5/2017 8:33:02 AM Cerus Unveils First Biologics License Application Approval For U.S. Blood Center Customer
8/2/2017 8:31:45 AM Cerus Corp. Enters Into $40 Mln Amended Growth Capital Agreement
5/15/2017 8:42:44 AM First Patient Transfused In Cerus’ Phase III RedeS Study Evaluating Efficacy Of INTERCEPT Red Blood Cell System